中国普外基础与临床杂志

中国普外基础与临床杂志

cN0T1/T2 期甲状腺乳头状癌中央区淋巴结清扫观点的变迁及反思

查看全文

引用本文: 赵淑艳, 马云海, 尹哲, 文天鋆, 刘彬, 程若川, 钱军. cN0T1/T2 期甲状腺乳头状癌中央区淋巴结清扫观点的变迁及反思. 中国普外基础与临床杂志, 2018, 25(7): 863-866. doi: 10.7507/1007-9424.201801095 复制

登录后 ,请手动点击刷新查看全文内容。 没有账号,
1. Chen AY, Jemal A, Ward EM. Increasing incidence of differentiated thyroid cancer in the United States, 1988-2005. Cancer, 2009, 115(16): 3801-3807.
2. Markovina S, Grigsby PW, Schwarz JK, et al. Treatment approach, surveillance, and outcome of well-differentiated thyroid cancer in childhood and adolescence. Thyroid, 2014, 24(7): 1121-1126.
3. 钱军, 马云海, 苏艳军, 等. 甲状腺乳头状癌中央区淋巴结清扫范围的合理选择. 中国肿瘤, 2015, 24(6): 444-447.
4. Sancho JJ, Lennard TW, Paunovic I, et al. Prophylactic central neck disection in papillary thyroid cancer: a consensus report of the European Society of Endocrine Surgeons (ESES). Langenbecks Arch Surg, 2014, 399(2): 155-163.
5. Zhang L, Wei WJ, Ji QH, et al. Risk factors for neck nodal metastasis in papillary thyroid microcarcinoma: a study of 1066 patients. J Clin Endocrinol Metab, 2012, 97(4): 1250-1257.
6. 刘文, 程若川, 苏艳军, 等. 2015 版美国甲状腺协会指南 cN0 甲状腺乳头状癌手术方案合理性分析. 中国实用外科杂志, 2017, 37(5): 568-571, 576.
7. Cooper DS, Doherty GM, Haugen BR, et al; American Thyroid Association (ATA) Guidelines Taskforce on Thyroid Nodules and Differentiated Thyroid Cancer. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid, 2009, 19(11): 1167-1214.
8. Oh EM, Chung YS, Lee YD. Clinical significance of Delphian lymph node metastasis in papillary thyroid carcinoma. World J Surg, 2013, 37(11): 2594-2599.
9. Lee YC, Shin SY, Kwon KH, et al. Incidence and clinical characteristics of prelaryngeal lymph node metastasis in papillary thyroid cancer. Eur Arch Otorhinolaryngol, 2013, 270(9): 2547-2550.
10. 王卓颖. 甲状腺微小癌中央区淋巴结清扫临床价值. 中国实用外科杂志, 2016, 36(5): 508-511.
11. Viola D, Materazzi G, Valerio L, et al. Prophylactic central compartment lymph node dissection in papillary thyroid carcinoma: clinical implications derived from the first prospective randomized controlled single institution study. J Clin Endocrinol Metab, 2015, 100(4): 1316-1324.
12. 高明. 甲状腺结节和分化型甲状腺癌诊治指南. 中国肿瘤临床, 2012, 39(17): 1249-1272.
13. Tuttle RM, Haddad RI, Ball DW, et al. Thyroid carcinoma, version 2. 2014. J Natl Compr Canc Netw, 2014, 12(12): 1671-1680.
14. 中国抗癌协会甲状腺癌专业委员会(CATO). 甲状腺微小乳头状癌诊断与治疗中国专家共识(2016 版). 中国肿瘤临床, 2016, 43(10): 405-411.
15. Barczyński M, Konturek A, Stopa M, et al. Nodal recurrence in the lateral neck after total thyroidectomy with prophylactic central neck dissection for papillary thyroid cancer. Langenbecks Arch Surg, 2014, 399(2): 237-244.
16. Haugen BR, Alexander EK, Bible KC, et al. 2015 American Thyroid Association Management Guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid, 2016, 26(1): 1-133.
17. 程若川. 2015 年版较 2009 年版 ATA 指南对甲状腺乳头状癌的手术治疗变化及解读. 中国普外基础与临床杂志, 2016, 23(10): 1166-1168.
18. Roh JL, Park JY, Park CI.Total thyroidectomy plus neck dissection in differentiated papillary thyroid carcinoma patients: pattern of nodal metastasis, morbidity, recurrence, and postoperative levels of serum parathyroid hormone. Ann Surg, 2007, 245(4): 604-610.
19. 程若川, 刘文. 再次手术中央区淋巴结清扫中甲状旁腺保护的难点及策略. 中国普外基础与临床杂志, 2017, 24(10): 1173-1179.
20. Lundgren CI, Hall P, Dickman PW, et al. Clinically significant prognostic factors for differentiated thyroid carcinoma: a population-based, nested case-control study. Cancer, 2006, 106(3): 524-531.
21. Randolph GW, Duh QY, Heller KS, et al. The prognostic significance of nodal metastases from papillary thyroid carcinoma can be stratified based on the size and number of metastatic lymph nodes, as well as the presence of extranodal extension. Thyroid, 2012, 22(11): 1144-1152.
22. 中国医师协会外科医师分会甲状腺外科医师委员会.甲状腺手术中甲状旁腺保护专家共识. 中国实用外科杂志, 2015, 35(7): 731-736.
23. Haser GC, Tuttle RM, Su HK, et al. Active surveillance for papillary thyroid microcarcinoma: new challenges and opportunities for the health care system. Endocr Pract, 2016, 22(5): 602-611.
24. 杭家伊, 王兆霞. 甲状腺癌术后患者自我管理效能水平及影响因素分析. 中国耳鼻咽喉颅底外科杂志, 2017, 24(2): 67-70.
25. Xue S, Wang P, Liu J, et al. Prophylactic central lymph node dissection in cN0 patientswith papillary thyroid carcinoma: a retrospective study in China. Asian J Surg, 2016, 39(3): 131-136.
26. 朱精强, 苏安平. 理性思辨: 甲状腺微小乳头状癌的诊治策略. 中国普通外科杂志, 2017, 26(5): 547-550.
27. Applewhite MK, James BC, Kaplan SP, et al. Quality of Life in Thyroid Cancer is Similar to That of Other Cancers with Worse Survival. World J Surg, 2016, 40(3): 551-561.
28. Aschebrook-Kilfoy B, James B, Nagar S, et al. Risk factors for decreased quality of life in thyroid cancer survivors: Initial Findings from the North American Thyroid Cancer Survivorship Study. Thyroid, 2015, 25(12): 1313-1321.
29. Hwang HS, Orloff LA. Efficacy of preoperative neck ultrasound in the detection of cervical lymph node metastasis from thyroid cancer. Laryngoscope, 2011, 121(3): 487-491.
30. Lee DW, Ji YB, Sung ES, et al. Roles of ultrasonography and computed tomography in the surgical management of cervical lymph node metastases in papillary thyroid carcinoma. Eur J Surg Oncol, 2013, 39(2): 191-196.
31. Khokhar MT, Day KM, Sangal RB, et al. Preoperative high-resolution ultrasound for the assessment of malignant central compartment lymph nodes in papillary thyroid cancer. Thyroid, 2015, 25(12): 1351-1354.
32. 王卓颖. 规范的甲状腺癌颈部淋巴结清扫是降低复发的关键. 外科理论与实践, 2016, 21(4): 300-302.
33. Mulla M, Schulte KM. Central cervical lymph node metastases in papillary thyroid cancer: a systematic review of imaging-guided and prophylactic removal of the central compartment. Clin Endocrinol (Oxf), 2012, 76(1): 131-136.
34. 赵淑艳, 马云海, 尹哲, 等. cN0T1/T2 期甲状腺乳头状癌行颈中央区淋巴结清扫的合理性及其范围的探讨.中华耳鼻咽喉头颈外科杂志, 2018, 53(2): 105-109.
35. 吴毅. 甲状腺结节外科治疗中值得关注的若干问题. 中国实用外科杂志, 2015, 35(6): 577-578, 583.
36. Shan CX, Zhang W, Jiang DZ, et al. Routine central neck dissection in differentiated thyroid carcinoma: a systematic review and meta-analysis. Laryngoscope, 2012, 122(4): 797-804.
37. Podnos YD, Smith D, Wagman LD, et al. The implication of lymph node metastasis on survival in patients with well-differentiated thyroid cancer. Am Surg, 2005, 71(9): 731-734.